| Financial Year |
March 31 2023 |
| Monetary Funds |
5,793,098,663.02 |
| Held-for-trading Financial Assets |
9,918,158.40 |
| Notes Receivable |
617,826,724.34 |
| Accounts Receivable |
8,552,744,453.00 |
| Advances to Suppliers |
1,099,548,901.37 |
| Other Receivables |
98,858,664.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,122,118,066.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
177,444,247.44 |
| Total Current Assets |
17,530,794,939.30 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
13,763,727,046.12 |
| Investment Properties |
-- |
| Fixed Assetes |
9,723,078.22 |
| Under-construction Projects |
14,812,392.64 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
68,531,873.98 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
157,358.94 |
| Deferred Income Tax Assets |
87,031,779.62 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
14,481,451,259.20 |
| Total Assets |
32,012,246,198.50 |
| Short-Term Loans |
1,841,880,938.15 |
| Trading Financial liabilities |
15,088,398.73 |
| Notes Payable |
6,094,258,696.30 |
| Accounts Payable |
11,772,592,147.83 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,091,783.40 |
| Taxes Payable |
128,785,217.51 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,107,661,657.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
150,749,980.50 |
| Other Current Liabilities |
933,584,292.03 |
| Sub-Total of Current Liabilities |
23,882,042,554.87 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
72,999,352.14 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
421,201,102.15 |
| Total Liabilities |
24,303,243,657.02 |
| Paid-In Capital(Or Share Stock) |
1,051,902,464.00 |
| Capital Surplus |
1,709,301,639.78 |
| Surplus Reserve |
260,701,884.78 |
| LESS:Treasury Stock |
50,999,548.73 |
| Undistributed Profits |
4,545,441,283.13 |
| Minority Stockholder's Interest |
39,419,988.40 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,669,582,553.08 |
| Owner's Equity（Stockholder's Equity） |
7,709,002,541.48 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
32,012,246,198.50 |
